|
Overview
of the Round Table
During the past
ten years, the Israeli biotechnology sector has begun to flourish and capture the
attention of professionals around the world. A recent study of the Biotech industry
conducted by the Office of the Chief Scientist in Israel indicates that the number
of companies in the sector has grown from 30 in 1990 to 160 and that the workforce
employed by these companies now numbers 4000, a significant increase from the 600
employed in 1990. It has been projected that the biotechnology industry will generate
annual revenues of between $2 billion- $3 billion by 2010.Underpinning and supporting
this phenomenal growth is an extensive array of research programs underway at Israel's
universities, specialized institutes, and hospitals, and substantial investments from
venture capitalists based in Israel, the US, Europe and Japan
While all of this
activity suggests that the industry will indeed develop into a leading center of
biotechnology, innovative enterprises in this sector face numerous managerial
challenges. These include creating an organization which can successfully capitalize
on both internal and external resources which are essential for developing biotech
products, developing the appropriate talent, and finding the right blend of
entrepreneurship and management. This Workshop will explore these challenges.
Drawing on the insights of experts from both Israel and the United States, we will
take a sophisticated in-depth look at such issues as:
- The optimal organizational approaches
for creating innovative biotechnology enterprises
- The role of large corporations in the
development of this sector
- The best strategy for nurturing relevant
leadership and talent in Israel
- Lessons that can be learned from
successful companies in the recently established Israeli high-tech industry
Round
Table Program
Wednesday January 9, 2002
5:00 - 8:15 PM
Weizmann Institute of Science, Ebner Hall, Rehovot, Israel
| 5:00
- 5:30 PM |
Registration
|
| 5:30
- 5:45 PM |
Welcome & Overview
Professor Ephraim Katzir, Weizmann Institute of Science
Professor Harold Kaufman, Polytechnic University
Professor Nina Ziv, Institute for Technology and Enterprise, Polytechnic University
|
| 5:45 -
8:00 PM |
Panel Discussion
Session Chair:
Professor Nina Ziv, Institute for Technology
and Enterprise, Polytechnic University
Speakers:
Lior Ma'ayan, Executive Vice President, Compugen
Dr. Martin Becker, CEO, XTL Biopharmaceuticals Ltd.
Neil Cohen, General Partner, Israel Seed Partners
Dr. Gal Ehrlich, Ehrlich and Partners
Professor Yair Berson, Institute for Technology and Enterprise, Polytechnic University
|
| 8:00 -
8:15 PM |
Lessons Learned and Wrap Up
Professor Nina Ziv, Institute for Technology and Enterprise, Polytechnic University
|
|